Highlights•QoL maintained after re-irradiation in patients with relapsed head and neck cancer.•Hyperfractionated re-irradiation was feasible for head and neck cancer patients.•High prevalence of toxicity at end of treatment.•The majority of patients alive at one and three years had received ≥60 Gy.